Table 1.
Number of deaths by treatment arm and factor subgroups n (%)
| Factor | Number of patients | Breast cancer | Other cause1 | P-value2 |
| Treatment | ||||
| Tamoxifen | 329 (50) | 50 | 32 | |
| Tamoxifen | ||||
| + Octreotide LAR | 329 (50) | 56 | 23 | 0.40 |
| Age | ||||
| < 70 | 544 (83) | 85 | 37 | |
| ≥ 70 | 114 (17) | 21 | 18 | 0.004 |
| BMI | ||||
| < 25 | 185 (28) | 30 | 7 | |
| 25-30 | 221 (34) | 29 | 20 | |
| > 30 | 213 (32) | 41 | 24 | 0.02 |
| Tumour size | ||||
| T1 | 382 (58) | 38 | 26 | |
| ≥ T2, unknown | 276 (42) | 68 | 29 | < 0.0001 |
| Nodal status | ||||
| N0 | 346 (53) | 39 | 29 | |
| N1, N2, Nx | 312 (47) | 67 | 26 | 0.002 |
1
Nine patients are excluded with unknown type of death;
2
P-value is based on Pearson chi-square test.